News-Good Doctor

Blog

——

2026.08.21

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (8) “A Comparative Study of the Efficacy of CCCHP and CHP in Treating Malignant Effusions”

Intracavitary hyperthermic perfusion chemotherapy devices can maintain an effective therapeutic temperature within the body cavity and ensure continuous circulation, with efficacy significantly superior to that of single‑dose, non‑circulatory intracavitary hyperthermic perfusion chemotherapy; there was no difference in the incidence of adverse events between the two groups.

2026.08.21

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (7) “Clinical Study on Cytoreductive Surgery Combined with Intraperitoneal Hyperthermic Perfusion Chemotherapy for Peritoneal Metastases of Gastric Cancer”

This study evaluated the therapeutic efficacy and adverse effects of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastases from gastric cancer, following cytoreductive surgery (CRS).

2026.07.17

[HIPEC Hyperthermic Intraperitoneal Chemotherapy Podcast Series] Episode 3: “The Efficacy of Hyperthermic Intraperitoneal Chemotherapy for Gynecologic Malignancies”

Welcome to the “HIPEC Hyperthermic Intraperitoneal Chemotherapy Podcast” series, where we will focus on the key issues in the field of hyperthermic therapy and delve into the clinical value, technical essentials, and practical applications of hyperthermic intraperitoneal chemotherapy.

2026.07.17

[HIPEC Hyperthermic Intraperitoneal Chemotherapy Podcast Series] Episode 2: “Is It Safe for Colorectal Cancer Patients to Undergo Hyperthermic Intraperitoneal Chemotherapy in Advance to Prevent Metastasis?”

2026.07.17

[HIPEC Hyperthermic Intraperitoneal Chemotherapy Podcast Series] Episode 1: “How Can We Keep the Treatment Temperature Within the Effective Range?”

2026.07.13

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (6) “Clinical Study on the Treatment of Advanced Gastric Cancer with Ascites Using Hyperthermic Intraperitoneal Chemotherapy”

Hyperthermic intraperitoneal chemotherapy demonstrates definitive efficacy in treating malignant ascites secondary to gastric cancer, while also improving patients’ quality of life and exhibiting a low incidence of adverse events, making it worthy of clinical adoption and broader application.

2026.07.10

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (5) “An Experimental Study on the Safety of Hyperthermic Perfusion Chemotherapy in Body Cavity Circulation”

This study investigated the effects of different temperatures during hyperthermic intraperitoneal chemotherapy (HIPEC) on the vital signs and intra-abdominal organs of experimental dogs, with the aim of determining the optimal temperature for HIPEC in this animal model. The results demonstrated that a temperature range of 42°C to 42.5°C is therapeutically appropriate, and that therapeutic efficacy is achieved only when the intraperitoneal temperature reaches 42.5°C.

2026.07.10

Building on Standards, Achieving Long-Term Success Through Collaboration—A New Chapter in the Diagnosis and Treatment of Peritoneal Tumors Begins

On July 2, 2026, the Inauguration Ceremony of the Peritoneal Cancer Prevention and Treatment Research Center of the Clinical Medical College of Tsinghua University, the Appointment Ceremony for International Experts in Peritoneal Tumors, and the Launch Meeting for Clinical Diagnosis and Treatment Standards for Pseudomyxoma Peritonei were held at Peking Union Medical College Hospital—Tsinghua University. Experts and scholars from both China and abroad attended, engaging in in-depth discussions on collaborative innovation in peritoneal cancer prevention and treatment, standardized diagnosis and management of pseudomyxoma peritonei, and the development of group standards.

< 1 2 3 4...11 > proceed page

· GDHIPEC from China ,

· Caring for Patients Worldwide ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Blog

COOKIES

COOKIES

Sorry，The current column has no content!